PF-04634817

Modify Date: 2024-04-05 18:52:05

PF-04634817 Structure
PF-04634817 structure
Common Name PF-04634817
CAS Number 1228111-63-4 Molecular Weight 511.58
Density N/A Boiling Point N/A
Molecular Formula C25H36F3N5O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of PF-04634817


PF-0463481, an oral CCR2/5 dual antagonist, with a favorable ocular safety profile versus intravitreal therapies[1]. PF-0463481 is safe and well-tolerated and being developed for the treatment of diabetic nephropathy[2].

 Names

Name PF-04634817

 PF-04634817 Biological Activity

Description PF-0463481, an oral CCR2/5 dual antagonist, with a favorable ocular safety profile versus intravitreal therapies[1]. PF-0463481 is safe and well-tolerated and being developed for the treatment of diabetic nephropathy[2].
Related Catalog
Target

CCR2

CCR5

References

[1]. Gale JD, et al. A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2659-2669.

[2]. Gale JD, et al. Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy. Kidney Int Rep. 2018 Aug 3;3(6):1316-1327.

 Chemical & Physical Properties

Molecular Formula C25H36F3N5O3
Molecular Weight 511.58